Controlled Release Antimicrobial Ear Formulations
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for otic disorders, such as otitis externa and otitis media, face challenges due to the susceptibility of the inner ear to infections, requiring stringent sterility and compatibility with the inner ear environment, and existing formulations often cause discomfort and systemic toxicity, with limited controlled release options and high frequency of administration.
Innovation Solution
Development of controlled release formulations for antimicrobial agents that are specifically designed for the ear, using auris-compatible excipients and delivery methods that ensure sterility, compatibility with inner ear fluids, and reduced dosing frequency, including polymers that gel at body temperature and mucoadhesives to adhere to otic surfaces, allowing for targeted and sustained release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antimicrobial formulations are administered to the ear, then immediate therapeutic effect is achieved, but frequent administration is required and systemic toxicity occurs
Solution Approach 1:
The patent applies preliminary action by incorporating antimicrobial agents into controlled-release formulations (such as gel capsules, implants, or coated devices) that are placed in the ear prior to infection or at the onset of infection. These formulations are designed to release the antimicrobial agent slowly over an extended period, thereby providing sustained therapeutic effect without requiring frequent re-administration. This resolves the contradiction by ensuring reliable therapeutic effect while extending the duration of action through pre-planned release mechanisms.
2Reliability
If high concentration of antimicrobial agents is used to ensure effectiveness, then therapeutic efficacy is improved, but systemic toxicity and discomfort increase
Solution Approach 1:
The patent applies local quality by designing controlled-release formulations that deliver high concentrations of antimicrobial agents locally at the site of infection in the ear, while the release rate is controlled to prevent systemic absorption. The formulation ensures that the high concentration remains confined to the local area (ear canal or middle ear), providing effective therapeutic action without causing systemic toxicity. This resolves the contradiction by maintaining high local efficacy while minimizing harmful systemic effects through spatial confinement of the drug concentration.
3Ease of operation
If liquid formulations are administered to the ear, then easy administration is achieved, but drainage and leakage occur reducing treatment efficacy
Solution Approach 1:
The patent applies phase transitions by using formulations that change from liquid to gel state upon contact with ear canal conditions (such as body temperature or moisture). The liquid formulation is easy to administer, but once in place, it undergoes phase transition to a gel that adheres to the ear canal walls and prevents drainage and leakage. This resolves the contradiction by maintaining ease of administration through liquid form during application, then preventing substance loss through phase transition to gel form that retains the antimicrobial agent at the target site.
4Duration of action of moving object
If controlled release formulations are developed for sustained release, then dosing frequency is reduced, but formulation complexity increases
Solution Approach 1:
The patent applies self-service by designing controlled-release formulations that automatically regulate the release of antimicrobial agents based on local conditions in the ear. The formulation contains embedded release mechanisms (such as pH-sensitive polymers, temperature-responsive gels, or osmotic pumps) that self-adjust the release rate without external intervention. This resolves the contradiction by achieving extended duration of release through self-regulating mechanisms, reducing dosing frequency while avoiding the need for complex external control systems or frequent medical interventions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulations provide a therapeutically effective, sustained release of antimicrobial agents with reduced systemic toxicity and discomfort, maintaining inner ear homeostasis and minimizing side effects, while avoiding drainage and leakage, thus improving treatment efficacy and patient experience.
Implementation Method 1
polymers that gel at body temperature
Implementation Method 2
mucoadhesives to adhere to otic surfaces
Data Source
AI summary
Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with antimicrobial agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).